Intensive insulin therapy with insulin lispro: A randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection

Diabetes Care

Volumn 24, Issue 10, 2001, Pages 1722-1727

  Tsui, Elaine ^a,b   Barnie, Annette ^a   Ross, Sue ^b,c   Parkes, Robert ^c   Zinman, Bernard ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN LISPRO;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGLYCEMIA; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INJECTIONS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 0035488933     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.10.1722     Document Type: Article

References (22)

1. The Diabetes Control and Complications Trial (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Mecklenburg RS, Benson EA, Benson JW Jr, Blumenstein BA, Fredlund PN, Guinn TS, Metz RJ, Nielsen RL: Long-term metabolic control with insulin pump therapy: report of experience with 127 patients. N Engl J Med 313:465-468, 1985
3. Santiago JV: Clinical review 38: intensive management of insulin dependent diabetes: risks, benefits, and unanswered questions. J Clin Endocrinol Metab 75:977-982, 1992
4. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19:324-327, 1996
5. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Angenaes O: Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J 293:1195-1199, 1986
6. Lee WL, Zinman B: From insulin to insulin analogs: progress in the treatment of type 1 diabetes. Diabetes Reviews 6:73-88, 1998
7. DiMarchi RD, Chance RE, Long HB, Shields JE, Slicker LJ: Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. Horm Res 41 (Suppl. 2):93-96, 1994
8. Howey DC, Bowsher RR, Brunelle RL, Rowe HM, Santa PF, Downing-Shelton J, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
9. Pfutzner A, Kustner E, Forst T, Schulze-Schleppinghoff B, Trautmann ME, Haslbeck M, Schatz H, Beyer J: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol 104:25-30, 1996
10. Brunelle RI, Anderson JH, Vignati L: Decreased rate if hypoglycemia in association with improved metabolic control with lispro insulin. Diabetologia 37 (Suppl. 1):A78, 1994
11. Anderson JH, Brunelle RL, Koivisto VA, Pfutzner A, Trautmann ME, Vignati L, DiMarchi R: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment: Multicenter Insulin Lispro Study Group. Diabetes 46:265-270, 1997
12. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH: Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro: the Benelux-UK Insulin Lispro Study Group. Diabetes Care 20:1827-1832, 1997
13. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T: Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 46:440-443, 1997
14. 1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 21:977-982, 1998
15. Renner R, Pfutzner A, Trautmann M, Harzer O, Sauter K, Landgraf R: Use of insulin lispro in continuous subcutaneous insulin infusion treatment: results of a multicenter trial: German Humalog-CSII Study Group. Diabetes Care 22:784-788, 1999
16. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP: Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study: the Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 23:1232-1235, 2000
17. MiniMed Technologies: The Insulin Pump Therapy Book Insights From The Experts. Hollywood, FL, MiniMed Technologies, 1998
18. The Diabetes Control and Complications Trial (DCCT) Research Group: Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 10:1-19, 1987
19. The Diabetes Control and Complications Trial (DCCT) Research Group: Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial. Diabetes Care 11:725-732, 1988
20. Littell RC, Milliken GA, Stroup WW, Wolfinger RD: SAS System for Mixed Models. Cary, NC, SAS Institute, 1996
21. Boland EA, Grey M, Oesterle A, Frederickson L, Tamborlane WV: Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22:1779-1184, 1999
22. Gillies PS, Figgitt DP, Lamb HM: Insulin glargine. Drugs 59:253-260, 2000